217 related articles for article (PubMed ID: 27432169)
1. Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.
Schaller M; Dirschka T; Kemény L; Briantais P; Jacovella J
Dermatol Ther (Heidelb); 2016 Sep; 6(3):427-36. PubMed ID: 27432169
[TBL] [Abstract][Full Text] [Related]
2. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
Taieb A; Stein Gold L; Feldman SR; Dansk V; Bertranou E
J Manag Care Spec Pharm; 2016 Jun; 22(6):654-65. PubMed ID: 27231793
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.
Taieb A; Khemis A; Ruzicka T; Barańska-Rybak W; Berth-Jones J; Schauber J; Briantais P; Jacovella J; Passeron T;
J Eur Acad Dermatol Venereol; 2016 May; 30(5):829-36. PubMed ID: 26691278
[TBL] [Abstract][Full Text] [Related]
6. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
Schaller M; Kemény L; Havlickova B; Jackson JM; Ambroziak M; Lynde C; Gooderham M; Remenyik E; Del Rosso J; Weglowska J; Chavda R; Kerrouche N; Dirschka T; Johnson S
J Am Acad Dermatol; 2020 Feb; 82(2):336-343. PubMed ID: 31150711
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta-analysis.
Husein-ElAhmed H; Steinhoff M
Dermatol Ther; 2020 Jan; 33(1):e13203. PubMed ID: 31863543
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
[TBL] [Abstract][Full Text] [Related]
10. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis.
Siddiqui K; Stein Gold L; Gill J
Springerplus; 2016; 5(1):1151. PubMed ID: 27504249
[TBL] [Abstract][Full Text] [Related]
11. Ivermectin: A Review in Rosacea.
Deeks ED
Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
Mazzetti A; Moro L; Gerloni M; Cartwright M
J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
[TBL] [Abstract][Full Text] [Related]
14. Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.
Webster G; Schaller M; Tan J; Jackson JM; Kerrouche N; Schäfer G
J Dermatolog Treat; 2017 Aug; 28(5):469-474. PubMed ID: 28617145
[TBL] [Abstract][Full Text] [Related]
15. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
Schaller M; Gonser L; Belge K; Braunsdorf C; Nordin R; Scheu A; Borelli C
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a cream containing modified glutathione (GSH-C4), beta-Glycyrrhetic, and azelaic acids in mild-to-moderate rosacea: A pilot, assessor-blinded, VISIA and ANTERA 3-D analysis, two-center study (The "Rosazel" Trial).
Dall'Oglio F; Puviani M; Milani M; Micali G
J Cosmet Dermatol; 2021 Apr; 20(4):1197-1203. PubMed ID: 32885541
[TBL] [Abstract][Full Text] [Related]
17. Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations.
Ebbelaar CCF; Venema AW; Van Dijk MR
Dermatol Ther (Heidelb); 2018 Sep; 8(3):379-387. PubMed ID: 29943217
[TBL] [Abstract][Full Text] [Related]
18. Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.
Rosso JQ; Draelos ZD; Effron C; Kircik LH
J Drugs Dermatol; 2021 Apr; 20(4):426-431. PubMed ID: 33852248
[TBL] [Abstract][Full Text] [Related]
19. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
[TBL] [Abstract][Full Text] [Related]
20. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]